March 18 (Reuters) - IMV Inc IMV.TO :
* IMV INC. LAUNCHES PLANS TO ADVANCE CLINICAL DEVELOPMENT OF A VACCINE CANDIDATE AGAINST COVID-19
* IMV INC - INTENDS TO DEVELOP ITS VACCINE CANDIDATE DPX-COVID-19 IN COLLABORATION WITH LEAD INVESTIGATORS FOR PHASE 1 CLINICAL STUDY